Misfolded proteins partition between two distinct quality control compartments

被引:719
作者
Kaganovich, Daniel [1 ,2 ]
Kopito, Ron [1 ,2 ]
Frydman, Judith [1 ,2 ]
机构
[1] Stanford Univ, Dept Biol, Stanford, CA 94305 USA
[2] Stanford Univ, BioX Program, Stanford, CA 94305 USA
关键词
D O I
10.1038/nature07195
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The accumulation of misfolded proteins in intracellular amyloid inclusions, typical of many neurodegenerative disorders including Huntington's and prion disease, is thought to occur after failure of the cellular protein quality control mechanisms. Here we examine the formation of misfolded protein inclusions in the eukaryotic cytosol of yeast and mammalian cell culture models. We identify two intracellular compartments for the sequestration of misfolded cytosolic proteins. Partition of quality control substrates to either compartment seems to depend on their ubiquitination status and aggregation state. Soluble ubiquitinated misfolded proteins accumulate in a juxtanuclear compartment where proteasomes are concentrated. In contrast, terminally aggregated proteins are sequestered in a perivacuolar inclusion. Notably, disease- associated Huntingtin and prion proteins are preferentially directed to the perivacuolar compartment. Enhancing ubiquitination of a prion protein suffices to promote its delivery to the juxtanuclear inclusion. Our findings provide a framework for understanding the preferential accumulation of amyloidogenic proteins in inclusions linked to human disease.
引用
收藏
页码:1088 / U36
页数:9
相关论文
共 57 条
[1]  
Adams A., 1997, METHODS YEAST GENETI
[2]   Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death [J].
Arrasate, M ;
Mitra, S ;
Schweitzer, ES ;
Segal, MR ;
Finkbeiner, S .
NATURE, 2004, 431 (7010) :805-810
[3]   Adapting proteostasis for disease intervention [J].
Balch, William E. ;
Morimoto, Richard I. ;
Dillin, Andrew ;
Kelly, Jeffery W. .
SCIENCE, 2008, 319 (5865) :916-919
[4]   Roles of molecular chaperones in protein misfolding diseases [J].
Barral, JM ;
Broadley, SA ;
Schaffar, G ;
Hartl, FU .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2004, 15 (01) :17-29
[5]   Impairment of the ubiquitin-proteasome system by protein aggregation [J].
Bence, NF ;
Sampat, RM ;
Kopito, RR .
SCIENCE, 2001, 292 (5521) :1552-1555
[6]   A yeast Ubc9 mutant protein with temperature-sensitive in vivo function is subject to conditional proteolysis by a ubiquitin- and proteasome-dependent pathway [J].
Betting, J ;
Seufert, W .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (42) :25790-25796
[7]   Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases [J].
Bucciantini, M ;
Giannoni, E ;
Chiti, F ;
Baroni, F ;
Formigli, L ;
Zurdo, JS ;
Taddei, N ;
Ramponi, G ;
Dobson, CM ;
Stefani, M .
NATURE, 2002, 416 (6880) :507-511
[8]   MULTIPLE UBIQUITIN-CONJUGATING ENZYMES PARTICIPATE IN THE IN-VIVO DEGRADATION OF THE YEAST MAT-ALPHA-2 REPRESSOR [J].
CHEN, P ;
JOHNSON, P ;
SOMMER, T ;
JENTSCH, S ;
HOCHSTRASSER, M .
CELL, 1993, 74 (02) :357-369
[9]   Protein misfolding, functional amyloid, and human disease [J].
Chiti, Fabrizio ;
Dobson, Christopher M. .
ANNUAL REVIEW OF BIOCHEMISTRY, 2006, 75 :333-366
[10]   Opposing activities protect against age-onset proteotoxicity [J].
Cohen, Ehud ;
Bieschke, Jan ;
Perciavalle, Rhonda M. ;
Kelly, Jeffery W. ;
Dillin, Andrew .
SCIENCE, 2006, 313 (5793) :1604-1610